MET and neuroblastoma: Kaplan–Meier survival analysis demonstrated that elevated MET expression strongly correlates with poor overall survival of NB patients (Kocak p = 3.1 × 10−8; SEQC p = 1.9 × 10−6; Versteeg p = 0.323; Figure 1A–C).